Neovasc Inc. (Nasdaq: NVCN) announced that following a trial in Boston, Massachusetts a jury found in favor of CardiAQ, on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE